Transforming-growth-factor-b	NN
inhibits	VBZ
IQ	NNP
motif	NN
containing	VBG
guanosine	NN
triphosphatase	NN
activating	VBG
protein	NN
1	CD
expression	NN
in	IN
lung	NN
fibroblasts	NNS
via	IN
the	DT
nuclear	JJ
factor-kB	NN
signaling	NN
pathway	NN
.	.

UNASSIGNED	NNP
:	:
IQ	NNP
motif	NN
containing	VBG
guanosine	NN
triphosphatase	NN
activating	VBG
protein	NN
1	CD
(	(
IQGAP1	NN
)	)
is	VBZ
associated	VBN
with	IN
idiopathic	JJ
pulmonary	JJ
fibrogenesis	NN
(	(
IPF	NN
)	)
;	:
however	RB
,	,
characterization	NN
of	IN
the	DT
expression	NN
of	IN
IQGAP1	NN
in	IN
lung	NN
fibroblasts	NNS
has	VBZ
remained	VBN
elusive	JJ
.	.

The	DT
present	JJ
study	NN
therefore	RB
evaluated	VBD
IQGAP1	NN
expression	NN
in	IN
mouse	NN
and	CC
human	JJ
lung	NN
fibroblasts	NNS
under	IN
fibrotic	JJ
conditions	NNS
via	IN
western	NN
blot	NN
analysis	NN
.	.

It	PRP
was	VBD
revealed	VBN
that	IN
IQGAP1	NN
expression	NN
levels	NNS
were	VBD
significantly	RB
decreased	VBN
in	IN
lung	NN
fibroblasts	NNS
isolated	VBN
from	IN
bleomycin	NN
-	:
challenged	VBN
mice	NNS
than	IN
in	IN
those	DT
of	IN
control	NN
mice	NNS
.	.

Transforming	VBG
growth	NN
factor	NN
-	:
b	NN
(	(
TGF	NN
-	:
b	LS
)	)
induced	VBD
differentiation	NN
,	,
as	RB
well	RB
as	IN
decreased	VBN
expression	NN
of	IN
IQGAP1	NN
in	IN
WI	NNP
-38	CD
cells	NNS
human	JJ
lung	NN
fibroblasts	NNS
.	.

Furthermore	RB
,	,
inhibition	NN
of	IN
nuclear	JJ
factor	NN
(	(
NF	NN
)	)
-	:
kB	NN
activation	NN
restored	VBD
the	DT
TGF	NN
-	:
b	SYM
-	:
induced	VBN
inhibition	NN
of	IN
IQGAP1	NN
expression	NN
in	IN
WI	NNP
-38	CD
cells	NNS
.	.

In	IN
lysophosphatidic	JJ
acid	NN
(	(
LPA	NN
)	)
-	:
challenged	VBN
WI	NNP
-38	CD
cells	NNS
,	,
the	DT
expression	NN
of	IN
IQGAP1	NN
was	VBD
also	RB
decreased	VBN
,	,
while	IN
neutralized	VBN
anti	JJ
-	:
TGF	NN
-	:
b	NN
antibody	NN
treatment	NN
restored	VBD
the	DT
LPA	NN
-	:
induced	VBN
inhibition	NN
of	IN
IQGAP1	NN
expression	NN
.	.

These	DT
data	NNS
indicated	VBD
that	IN
TGF	NN
-	:
b	NN
inhibited	VBD
IQGAP1	NN
expression	NN
in	IN
lung	NN
fibroblasts	NNS
via	IN
the	DT
NF	NN
-	:
kB	NN
signaling	NN
pathway	NN
,	,
presenting	VBG
a	DT
potential	JJ
novel	JJ
therapeutic	JJ
target	NN
for	IN
the	DT
treatment	NN
of	IN
IPF	NN
.	.

